The aim of this review article is to focus on recently discovered autoantibodies against neuronal targets identified in syndromes cerebellar ataxia and includes two clinical case examples of adaptor protein-3B2 (AP3B2) and tripartite motif-containing (TRIM)-46. This evidence concerns the gene AP3B2 and cerebellar ataxia.